Serological identification of immunogenic antigens in acute monocytic leukemia

Leukemia Research

Volumn 29, Issue 5, 2005, Pages 503-509

  Chen, Gang ^a   Zhang, Wanggang ^a   Cao, Xingmei ^a   Li, Fuyang ^b   Liu, Xinping ^b   Yao, Libo ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute leukemia; Leukemia associated antigens; SEREX

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LEUKEMIA ANTIGEN;

ACUTE MONOCYTIC LEUKEMIA; ANTIGEN SPECIFICITY; ARTICLE; BLOOD ANALYSIS; CLONING; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; DNA SEQUENCE; GENE EXPRESSION; GENE LIBRARY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOTHERAPY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROLOGY;

EID: 14744277041     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.09.013     Document Type: Article

References (36)

1. P. van der Bruggen, C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, and B. Van den Eynde A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 54 1991 1643 1647
2. U. Sahin, O. Tureci, H. Schmitt, B. Cochlovius, T. Johannes, and R. Schmits Human neoplasms elicit multiple specific immune responses in the autologous host Proc Natl Acad Sci U S A 92 1995 11810 11813
3. M.J. Scanlan, J.D. Gordan, B. Williamson, E. Stockert, N.H. Bander, and V. Jongeneel Antigens recognized by autologous antibody in patients with renal-cell carcinoma Int J Cancer 83 1999 456 464
4. Y.T. Chen, M.J. Scanlan, U. Sahin, O. Tureci, A.O. Gure, and S. Tsang A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening Proc Natl Acad Sci U S A 94 1997 1914 1918
5. A.O. Gure, N.K. Altorki, E. Stockert, M.J. Scanlan, L.J. Old, and Y.T. Chen Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3 Cancer Res 58 1998 1034 1041
6. M.J. Scanlan, Y.T. Chen, B. Williamson, A.O. Gure, E. Stockert, and J.D. Gordan Characterization of human colon cancer antigens recognized by autologous antibodies Int J Cancer 76 1998 652 658
7. D. Jager, E. Stockert, M.J. Scanlan, A.O. Gure, E. Jager, and A. Knuth Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene Cancer Res 59 1999 6197 6204
8. H. Inoue, M. Mori, M. Honda, J. Li, K. Shibuta, and K. Mimori The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma Gastroenterology 109 1995 1522 1525
9. W.G. Zhang, S.H. Liu, X.M. Cao, Y.X. Chen, X.R. Ma, and Y. Yang A phase I clinical trial of active immunotherapy for acute leukemia using inactivated autologous leukemia cells mixed with IL-2, GM-CSF and IL-6 Leukemia Res 29 2005 3 9
10. B.D. Harrison, J.A. Adams, M. Briggs, M.L. Brereton, and J.A. Yin Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia Blood 97 2001 2764 2771
11. J. Greiner, M. Ringhoffer, O. Simikopinko, A. Szmaragowska, S. Huebsch, and U. Maurer Simultaneous expression of different immunogenic antigens in acute myeloid leukemia Exp Hematol 28 2000 1413 1422
12. A.M. Krackhardt, M. Witzens, S. Harig, F.S. Hodi, A.J. Zauls, and M. Chessia Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX Blood 100 2002 2123 2131
13. S.A. Rogers, D.J. Bowen, M. Ling, P. Thomson, Z. Wang, and S.H. Lim Identification and characterization of a novel gene encoding a SEREX antigen in chronic myeloid leukaemia Br J Haematol 119 2002 112 114
14. J. Greiner, M. Ringhoffer, M. Taniguchi, T. Hauser, A. Schmitt, and H. Dohner Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia Int J Cancer 106 2003 224 231
15. P.G. Coulie, P. Weynants, F. Lehmann, J. Herman, V. Brichard, and T. Wolfel Genes coding for tumor antigens recognized by human cytolytic T lymphocytes J Immunother 14 1993 104 109
16. Y. Ke, H. Ma, and J.A. Kapp Antigen is required for the activation of effector activities, whereas interleukin 2 Is required for the maintenance of memory in ovalbumin-specific, CD8+ cytotoxic T lymphocytes J Exp Med 187 1998 49 57
17. S. Lucas, C. De Smet, K.C. Arden, C.S. Viars, B. Lethe, and C. Lurquin Identification of a new MAGE gene with tumor-specific expression by representational difference analysis Cancer Res 58 1998 743 752
18. B. Lethe, S. Lucas, L. Michaux, C. De Smet, D. Godelaine, and A. Serrano LAGE-1, a new gene with tumor specificity Int J Cancer 76 1998 903 908
19. F. Muscatelli, A.P. Walker, E. De Plaen, A.N. Stafford, and A.P. Monaco Isolation and characterization of a MAGE gene family in the Xp21.3 region Proc Natl Acad Sci U S A 92 1995 4987 4991
20. J. Li, Y. Yang, T. Fujie, K. Baba, H. Ueo, and M. Mori Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma Clin Cancer Res 2 1996 1619 1625
21. V. Brichard, A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, and B. Lethe The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J Exp Med 178 1993 489 495
22. A.B. Bakker, M.W. Schreurs, A.J. de Boer, Y. Kawakami, S.A. Rosenberg, and G.J. Adema Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes J Exp Med 179 1994 1005 1009
23. P. Hammel, B. Boissier, M.T. Chaumette, P. Piedbois, N. Rotman, and J.C. Kouyoumdjian Detection and monitoring of serum p53 antibodies in patients with colorectal cancer Gut 40 1997 356 361
24. J.P. Peyrat, J. Bonneterre, R. Lubin, L. Vanlemmens, J. Fournier, and T. Soussi Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer Lancet 345 1995 621 622
25. R. Lubin, G. Zalcman, L. Bouchet, J. Tredanel, Y. Legros, and D. Cazals Serum p53 antibodies as early markers of lung cancer Nat Med 1 1995 701 702
26. P.F. Robbins, M. El-Gamil, Y.F. Li, Y. Kawakami, D. Loftus, and E. Appella A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes J Exp Med 183 1996 1185 1192
27. F. Di Modugno, G. Bronzi, M.J. Scanlan, D. Del Bello, S. Cascioli, and I. Venturo Human mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response Int J Cancer 109 2004 909 918
28. D.R. Surman, M.E. Dudley, W.W. Overwijk, and N.P. Restifo Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen J Immunol 164 2000 562 565
29. L. Sherman, J. Sleeman, P. Herrlich, and H. Ponta Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression Curr Opin Cell Biol 6 1994 726 733
30. V. Abetamann, H.F. Kern, and H.P. Elsasser Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells Clin Cancer Res 2 1996 1607 1618
31. P. Teder, J. Bergh, and P. Heldin Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines Cancer Res 55 1995 3908 3914
32. J. Greiner, M. Ringhoffer, M. Taniguchi, A. Schmitt, D. Kirchner, and G. Krahn Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia Exp Hematol 30 2002 1029 1035
33. O. Larbolette, B. Wollscheid, J. Schweikert, P.J. Nielsen, and J. Wienands SH3P7 is a cytoskeleton adapter protein and is coupled to signal transduction from lymphocyte antigen receptors Mol Cell Biol 19 1999 1539 1546
34. J. Dakour, H. Li, and D.W. Morrish PL48: a novel gene associated with cytotrophoblast and lineage-specific HL-60 cell differentiation Gene 185 1997 153 157
35. T. Nakatsura, S. Senju, M. Ito, Y. Nishimura, and K. Itoh Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method Eur J Immuno 32 2002 826 836
36. Wagner C, Neumann F, Kubuschok B, Regitz E, Mischo A, Stevanovic S, et al. Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2. Cancer Immun 2003;3:18.